部分乙肝后肝硬化失代偿期患者HBV-DNA处于高水平复制状态,伴有明显的肝细胞坏死和炎症,积极有效的抗病毒治疗对降低肝组织的炎症坏死,阻止乙肝后肝硬化失代偿期病情进一步恶化具有重要意义~([1])。现将西平县人民医院2013年1月—2015年1月收治的106例乙肝后肝硬化失代偿期患者应用恩替卡韦联合安络化纤丸片治疗效果报告如下:1资料与方法1.1病例选择入选标准:(1)均符合2000年西安会议通过的“病毒性肝炎防治方案”中肝硬化失代 HBV-DNA in some patients with decompensated hepatitis B is in a high-level replication state with obvious hepatocyte necrosis and inflammation. Active and effective antiviral therapy can reduce inflammation and necrosis of liver tissue and prevent the loss of liver cirrhosis The further worsening of the pay period is of great importance ~ ([1]). Now Xiping County People’s Hospital January 2013-January 2015 admitted 106 cases of hepatitis B cirrhosis decompensated patients with entecavir joint security network chemical fiber pellets reported as follows: 1 Materials and Methods 1.1 Case Selection Inclusion criteria : (1) are in line with the 2000 Xi’an conference passed “viral hepatitis prevention and treatment program ” in the loss of liver cirrhosis